NCT02076529View on ClinicalTrials.gov

Phamacokinetic and Pharmacodynamic Study of Ramosetron in Chemotherapy Induced Nasea and Vomiting

NACompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Colon Cancer
Interventions
DRUG

Ramosetron 0.3mg

DRUG

Ramosetron 0.45mg

DRUG

Ramosetron 0.6mg

Trial Locations (1)

519-809

Chonnam National University Hwasun Hospital, Gwangju

All Listed Sponsors
lead

Chonnam National University Hospital

OTHER

NCT02076529 - Phamacokinetic and Pharmacodynamic Study of Ramosetron in Chemotherapy Induced Nasea and Vomiting | Biotech Hunter | Biotech Hunter